FDA Public Advisory Committee Meeting --- September 6 and 7, 2006

[Guest guest]

--- " Kuntze, M " <patricia.kuntze@...>

wrote:

>> Subject: FDA Public Advisory Committee Meeting ---

> September 6 and 7,

> 2006

> Date: Wed, 10 May 2006 18:00:27 -0400

>

> Dear Colleague,

>

> Thank you for writing us about the upcoming public

> advisory

> committee meeting to review and discuss

> peer-reviewed scientific literature

> on dental amalgam devices. (See

>

http://www.fda.gov/oc/advisory/accalendar/2006/cdrh12518dd09060706.html

>

<http://www.fda.gov/oc/advisory/accalendar/2006/cdrh12518dd09060706.html>

> )

>

> We appreciate your taking the time to let us know

> your thoughts on

> the importance of this joint committee meeting. FDA

> is strongly committed

> to public participation in its decision making

> processes and carefully

> considers the views of all FDA stakeholders.

>

> We have forwarded your email to Adjodha,

> Executive Secretary

> and key FDA contact for the public meeting. We are

> including your email

> address on the outreach network so that we can send

> you timely information

> related to the public meeting. Please let us know

> if you do not wish to be

> included on this network and we will promptly remove

> your email address from

> the list.

>

> In addition, FDA encourages the public to report

> adverse events or

> problems with medical products to its Medwatch

> program. Medwatch can be

> accessed on the FDA Web page located at

> http://www.fda.gov/medwatch/

> <http://www.fda.gov/medwatch/>

>

> Again, thank you for sending your views related to

> this upcoming

> meeting to Associate Commissioner Lutter and Acting

> Associate Commissioner

> Brodsky.

>

> Sincerely,

>

> M. Kuntze

> Senior Advisor for Consumer Affairs

> Food and Drug Administration

>

>